Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator vegasdrummer, 1-eye-jack, stockchaser64, Meach2, matticus22, Shotime66
Search This Board:
Last Post: 8/27/2014 8:52:05 AM - Followers: 494 - Board type: Free - Posts Today: 3

Entest BioMedical Inc. (ENTB)





Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance

Share Structure:

ENTB = O/S = 1,873,070,000  

ENTB = A/S = 2,000,000,000 

Updated by calling the T/A 5/05/2014

ENTB Transfer Agent 

Securities Transfer Corporation 
2591 Dallas Parkway Suite 102 
Frisco, Texas 75034 

Fax: 469-633-0088 
Phone: 469-633-0101 then push 201 & Talk to Marilyn wink 






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Current Report Filing (8-k) 07/14/2014 04:36:32 PM
ENTB News: Quarterly Report (10-q) 07/09/2014 03:42:59 PM
ENTB News: Current Report Filing (8-k) 05/23/2014 03:59:42 PM
#34905  Sticky Note ~ ENTB = Today's Filing is a Sure~Sign..that..a..R/S 1-eye-jack 05/23/14 04:26:08 PM
#34823  Sticky Note What's he running? ENTB is a SKIPPERANDGILLIGAN 05/20/14 11:03:15 AM
#34692  Sticky Note ENTB-FOLLOWS-BMSN! SUBSIDIARY,DIRECTLY RELATED IN VALUE!~ Meach2 05/13/14 07:12:16 PM
#35683   1 eye joke has been buying this whole $tock_Killa 08/27/14 08:52:05 AM
#35682   Thank you for your insight Paris :) Kbro13 08/27/14 08:06:45 AM
#35681   You're going to have to put in overtime Natureboy1 08/27/14 02:28:40 AM
#35680   ENTB IS A TOTAL LOSER FOR ALMOST TEN parrishilton 08/26/14 11:42:35 PM
#35679   I believe your right, PoPo found another Phd NEW4THIS 08/26/14 04:33:22 PM
#35678   NEW4, i think that is the OTHER David ctvette2003 08/26/14 04:19:28 PM
#35677   Tempting here at these levels. Is the R/S SKIPPERANDGILLIGAN 08/26/14 02:43:18 PM
#35676   "Saban Research Institute of Children's Hospital Los Angeles NEW4THIS 08/26/14 02:05:21 PM
#35675   Smart move, as icing on the cake. Kbro13 08/26/14 01:32:15 PM
#35674   Agreed, just looking to grab some 3s if 72chevnj 08/26/14 01:18:10 PM
#35673   If you can get them. Kbro13 08/26/14 01:14:36 PM
#35672   Never thought we would see 3's here, time 72chevnj 08/26/14 01:03:23 PM
#35671   Thanks for the cheapies on BMSN and ENTB prof81 08/26/14 12:00:09 PM
#35670   GM NEW4THIS. Thanks for the link. Go ENTB/BMSN $kytrader 08/26/14 09:41:36 AM
#35669   GM $kytrader, apologize, it's an old article, I NEW4THIS 08/26/14 09:38:30 AM
#35668   When one -eye Jack turns bullish, but Lockman 08/25/14 03:17:04 PM
#35667   ENTB is very promising, I will be happy $kytrader 08/25/14 09:55:46 AM
#35666 NEW4THIS 08/25/14 09:20:30 AM
#35665   If you bought 2 million shares of ENTB Natureboy1 08/24/14 06:06:35 PM
#35664   I will buy more shares tomorrow as well. Pistol Pete! PetePham 08/24/14 02:33:19 PM
#35663   Got me 2 milly mo to add to Natureboy1 08/22/14 04:04:30 PM
#35662   Logic and rationale will prevail....whenever it decides to. bucks2pennies 08/22/14 02:50:15 PM
#35661   ~ ENTB = 0.0003 -0.0001 (-25.00%) :-( 1-eye-jack 08/22/14 02:26:43 PM
#35660   If you are implying that ENTB or BMSN LetsRoll9696 08/22/14 09:26:51 AM
#35659   ENTB - Kbro13 08/22/14 08:25:46 AM
#35658   RNAi and stem cell research could there be 02tampabay 08/22/14 05:33:24 AM
#35657   $ENTB. That is all. Meach2 08/22/14 12:17:43 AM
#35656   ~ ENTB = ZZZZZzzzzz! :-( 1-eye-jack 08/21/14 03:52:15 PM
#35655   order in for 3 m jeffshir 08/21/14 11:43:53 AM
#35654   And Koos, too: Angel 11 08/21/14 11:03:53 AM
#35653   STRonG BUY ALERT!!! No downtrend in sight. Charts prof81 08/21/14 12:12:37 AM
#35652   Sorry, I stand corrected. Kbro13 08/20/14 03:19:05 PM
#35651   ENTB STOCK look like interest has fading big stockchaser64 08/20/14 03:18:49 PM
#35650   5's up. Kbro13 08/20/14 03:14:14 PM
#35649   Agreed. Kbro13 08/20/14 03:14:04 PM
#35648   Yes that to start. ENTB now has been JokersWild12 08/20/14 03:05:02 PM
#35647   111M Bid @ 0.0003 vs 6.4M Ask @ Kbro13 08/20/14 01:37:37 PM
#35646   I feel IND will send this much higher Kbro13 08/20/14 12:27:49 PM
#35645   Dear wealthrupennies, This is a long term investment. I PetePham 08/20/14 12:17:02 PM
#35644   Pete- what's the buy story here? Ask wealththrupennies 08/20/14 12:13:50 PM
#35643   80.8M Bid @ 0.0003 Kbro13 08/20/14 11:52:53 AM
#35642   Looks like hmmmmmm scratch your head shorts. You prof81 08/19/14 02:18:10 PM
#35641   or submittal to Dept of Agriculture (for Veterinary medicines) jeffshir 08/19/14 01:27:52 PM
#35640   Agreed! With her at the helm, there will be Kbro13 08/19/14 01:24:49 PM
#35639   Should be getting a PR re: Dr Ichim's jeffshir 08/19/14 01:19:04 PM
#35638 Welcome to the Entest Angel 11 08/18/14 02:07:25 PM
#35636   HAHAHAHAHAHAHAHA a "micro miracle" a STINKY PINKY riggggghhhhhhhhhht! That angelicsatan666 08/18/14 06:51:39 AM
#35635   Yawnnnnn--did someone say a STINKY PINKY was a angelicsatan666 08/18/14 06:47:23 AM
#35634   The July 17th "Animal Medicine" article is exactly bucks2pennies 08/17/14 08:21:08 PM
#35633   Regen/ENTB/BMSN paving the way: Angel 11 08/15/14 10:45:00 AM